Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Pioneering differentiated therapies for the treatment of inflammation and immunology (NI&I)50M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States50M100.00%